General Atlantic, L.P. reported 12 positions worth $2.91B for the quarter ended Jun 30, 2026, up 44.0% on the prior quarter. It opened 3 new positions, added to 1, trimmed 3 and exited 1. Its largest holding is Liftoff Mobile, Inc. at 20.9% of the portfolio.
Reported 13F market value at each quarter end. A change mixes trading with price moves in the positions held.
Dollar value of shares bought and sold each quarter, at that quarter’s price. It counts trading only, not price changes.
How many positions were opened, added to, trimmed or closed each quarter.
Share of reported value in each sector at every quarter end.
| Holding | Shares Sold | Trade Value | Prior Weight |
|---|---|---|---|
| BULL Webull Corp | -50.8K | $243.92K | 0.012% |
| # | Activity | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | LFTO Liftoff Mobile, Inc. | Technology | 25.32M | $608.08M | 20.92% | +25.32M | – | New | 14.95% |
| 2 | DLO dLocal Ltd | Technology | 46.66M | $606.30M | 20.86% | 0 | 0.0% | Unchanged | 16.03% |
| 3 | CHYM Chime Financial, Inc. | Technology | 21.26M | $435.40M | 14.98% | 0 | 0.0% | Unchanged | 5.6% |
| 4 | ALKT Alkami Technology, Inc. | Technology | 19.38M | $351.15M | 12.08% | +4.04M | +26.4% | Added | 18.12% |
| 5 | XP XP Inc. | Financial Services | 20.57M | $334.41M | 11.5% | 0 | 0.0% | Unchanged | 3.9% |
| 6 | PHVS Pharvaris N.V. | Healthcare | 6.55M | $226.53M | 7.79% | -1.48M | -18.4% | Reduced | 11.07% |
| 7 | SPTX Seaport Therapeutics, Inc. | Healthcare | 6.10M | $132.53M | 4.56% | +6.10M | – | New | 11.4% |
| 8 | NRIX Nurix Therapeutics, Inc. | Healthcare | 3.03M | $73.56M | 2.53% | -1.07M | -26.1% | Reduced | 2.73% |
| 9 | RVMD Revolution Medicines, Inc. | Healthcare | 357.8K | $67.01M | 2.31% | -350.0K | -49.4% | Reduced | 0.17% |
| 10 | PBLS Parabilis Medicines, Inc. | Healthcare | 1.54M | $42.11M | 1.45% | +1.54M | – | New | 1.26% |
| 11 | RSKD Riskified Ltd. | Technology | 5.32M | $26.84M | 0.923% | 0 | 0.0% | Unchanged | 3.38% |
| 12 | GROV Grove Collaborative Holdings, Inc. | Consumer Staples | 2.47M | $3.09M | 0.106% | 0 | 0.0% | Unchanged | 6.1% |
Tip. Select a row to see that position’s full history at General Atlantic.
As of its Q2 2026 13F filing, General Atlantic, L.P.’s five largest positions were Liftoff Mobile, Inc. (LFTO) at 20.9%, dLocal Ltd (DLO) at 20.9%, Chime Financial, Inc. (CHYM) at 15.0%, Alkami Technology, Inc. (ALKT) at 12.1%, XP Inc. (XP) at 11.5% of the reported portfolio.
General Atlantic, L.P. reported a 13F portfolio worth $2.91B across 12 positions for Q2 2026. That is up 44.0% from the previous quarter.
Its largest purchases by value were Liftoff Mobile, Inc. ($608.08M), Seaport Therapeutics, Inc. ($132.53M), Alkami Technology, Inc. ($73.23M). It opened 3 new positions.
Its largest sales by value were Revolution Medicines, Inc. ($65.55M), Pharvaris N.V. ($51.20M), Nurix Therapeutics, Inc. ($25.95M). It exited 1 positions entirely.
From the Form 13F-HR reports General Atlantic, L.P. files with the SEC each quarter, within 45 days of quarter end. A 13F lists long positions in US-listed equities and options; it excludes short positions, cash, bonds and most non-US holdings.
13F data reflects long positions in US-listed equities and options as reported to the SEC up to 45 days after quarter end. It excludes short positions, cash, bonds and most non-US securities, so it is not a complete picture of a manager’s assets.